Free Trial

Treace Medical Concepts (TMCI) Earnings Date, Estimates & Call Transcripts

Treace Medical Concepts logo
$7.81 -0.17 (-2.13%)
(As of 09:56 AM ET)

Treace Medical Concepts Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 25Estimated
Actual EPS
(Nov. 5)
-$0.25 Beat By $0.02
Consensus EPS
(Nov. 5)
-$0.27

Treace Medical Concepts released Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.25, which topped the consensus estimate of -$0.27 by $0.02. Quarterly revenue rose 10.6% year-over-year to $45.09 million, above the consensus estimate of $43.48 million. With a trailing EPS of -$0.99, Treace Medical Concepts' earnings are expected to grow next year, from ($0.92) to ($0.77) per share.

TMCI Upcoming Earnings

Treace Medical Concepts' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules.

Get Treace Medical Concepts Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TMCI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TMCI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Treace Medical Concepts Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.92) EPS
Next Year EPS Consensus Estimate: ($0.77) EPS

Treace Medical Concepts Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/25/2025
(Estimated)
------- 
11/5/2024Q3 2024-$0.27-$0.25+$0.02-$0.25$43.48M$45.09M    
8/6/2024Q2 2024-$0.29-$0.34 -$0.05-$0.34$43.00M$44.46M      
5/7/2024Q1 2024-$0.30-$0.30--$0.30$49.07M$51.11M      
2/27/2024Q4 2023-$0.09-$0.10 -$0.01-$0.10$60.56M$62.20M      
11/9/2023Q3 2023-$0.26-$0.28 -$0.02-$0.28$42.08M$40.76M      
8/8/2023Q2 2023-$0.23-$0.20+$0.03-$0.20$40.84M$41.95M      
5/8/2023Q1 2023-$0.23-$0.23--$0.23$39.48M$42.20M  
3/7/2023Q4 2022-$0.13-$0.08+$0.05-$0.08-$49.77M      

Treace Medical Concepts Earnings - Frequently Asked Questions

Treace Medical Concepts has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on TMCI's earnings history.

Treace Medical Concepts updated its FY 2024 earnings guidance on Tuesday, November, 5th. The company issued revenue guidance of $204.0 million-$211.0 million, compared to the consensus revenue estimate of $206.0 million.

In the previous quarter, Treace Medical Concepts (NASDAQ:TMCI) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.02. Learn more on analysts' earnings estimate vs. TMCI's actual earnings.

The conference call for Treace Medical Concepts's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Treace Medical Concepts's latest earnings report can be read online.
Read Transcript

Treace Medical Concepts (NASDAQ:TMCI) has a recorded annual revenue of $187.12 million.

Treace Medical Concepts (NASDAQ:TMCI) has a recorded net income of -$49.53 million. TMCI has generated -$0.99 earnings per share over the last four quarters.

Treace Medical Concepts's earnings are expected to grow from ($0.92) per share to ($0.77) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:TMCI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners